Cerebrospinal fluid concentration of fibronectin in patients with HIV-1 infection and central nervous system disorders.

AIMS--To evaluate the fibronectin concentrations in the cerebrospinal fluid of HIV-1 infected patients with central nervous system disorders. METHODS--Fibronectin was determined by an immunoturbidimetric assay in 41 HIV-1 infected patients with AIDS dementia complex, progressive multifocal leucoencephalopathy, and opportunistic infections. RESULTS--A significant decrease in fibronectin concentrations in the cerebrospinal fluid of patients with AIDS and dementia complex and progressive multifocal leucoencephalopathy was observed, as well as in those with opportunistic infections of the central nervous system (p < 0.0001). In particular, a significant decrease in fibronectin concentration in cerebrospinal fluid was observed in patients with cerebral toxoplasmosis and cryptococcal meningitis (p < 0.0001). CONCLUSIONS--Because fibronectin can bind to several viruses, fungi, and protozoa, it is conceivable to suppose that the consumption of fibronectin in the cerebrospinal fluid of patients with neurological disorders may be related to the binding of fibronectin to HIV itself, or to viral proteins, or to organisms responsible for opportunistic infections.

[1]  D. Torre,et al.  Cerebrospinal fluid concentration of fibronectin in meningitis. , 1991, Journal of clinical pathology.

[2]  M. Weller,et al.  Increased intrathecal synthesis of fibronectin in bacterial and carcinomatous meningitis , 1990, Acta neurologica Scandinavica.

[3]  D. Torre,et al.  Plasma fibronectin concentrations in patients with human immunodeficiency virus infection. , 1990, Journal of clinical pathology.

[4]  D. Wyler.  Fibronectin in parasitic diseases. , 1987, Reviews of infectious diseases.

[5]  T. Kirkwood,et al.  Fibronectin is expressed by astrocytes cultured from embryonic and early postnatal rat brain. , 1986, Experimental cell research.

[6]  D. Mosher,et al.  Role of fibronectin in human monocyte and macrophage bactericidal activity , 1985, Infection and immunity.

[7]  W. Scheld,et al.  In vitro binding of Candida albicans yeast cells to human fibronectin. , 1984, Canadian journal of microbiology.

[8]  J. Keski‐Oja,et al.  Interaction of viral envelope glycoproteins with fibronectin , 1983, Infection and immunity.

[9]  B. Boughton,et al.  FUNCTIONAL HYPOSPLENISM DURING PNEUMOCOCCAL SEPTICAEMIA , 1983, The Lancet.

[10]  B. Boughton,et al.  Plasma fibronectin in acute leukaemia , 1982, British journal of haematology.

[11]  C. Jarstrand,et al.  Fibronectin increases the motility, phagocytosis and NBT (nitroblue tetrazolium)-reduction of granulocytes. , 1980, Journal of clinical & laboratory immunology.

[12]  E. Engvall,et al.  Fibronectin: current concepts of its structure and functions. , 1980, Collagen and related research.

[13]  E. Ruoslahti,et al.  Demonstration of fibronectin in human cerebrospinal fluid. , 1978, The Journal of laboratory and clinical medicine.

[14]  Williams Em,et al.  Fibronectin concentration is decreased in plasma of severely ill patients with disseminated intravascular coagulation. , 1978 .